Approval · Notice of Compliance 3666 · 1997
DALACIN: Notice of Compliance 3666
Issued September 30, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3666
- Date
- September 30, 1997
- Company
- Pharmacia & Upjohn Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antibiotic
Products in this notice
Medicinal ingredients
- CLINDAMYCIN HCL 150 MG per CAP
- CLINDAMYCIN HCL 300 MG per CAP